Foch Hospital is a celebrated teaching hospital in the Suresnes, France. Part of the Établissement de santé privé d'intérêt collectif and a teaching hospital of Versailles Saint-Quentin-en-Yvelines University, it is one of Europe's largest hospitals.

There are 600 beds in Hopital Foch; Neurologie.

During the past decade, Hopital Foch; Neurologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Foch; Neurologie" are "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Hopital Foch; Neurologie" in a lesser frequency.

Most popular intervention types in "Hopital Foch; Neurologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (1 trials), "Ocrelizumab 300 mg" (1 trials) and "Ocrelizumab 600 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Foch; Neurologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Foch; Neurologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hopital Foch; Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Foch; Neurologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".